Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.

Scope of the Report:

The worldwide market for Nuclear Medicine Radioisotopes is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.

This report focuses on the Nuclear Medicine Radioisotopes in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Agfa-Gevaert Group

Braco

Cardiarc

Cardinal Health

CMR Naviscan (Gamma Medica Inc.)

Curium

Digirad

GE Healthcare

Nordion (Canada)

NTP Radioisotopes SOC

Positron

Segami

Siemens Healthcare

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Thallium-201 (Tl-201)

Iodine (I-123)

Fluorine-18

Rubidium-82 (Rb-82)

Other

Market Segment by Applications, can be divided into

Tumor

Heart Disease

Lymphoma

Thyroid Gland

Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Nuclear Medicine Radioisotopes product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Nuclear Medicine Radioisotopes, with price, sales, revenue and global market share of Nuclear Medicine Radioisotopes in 2017 and 2018.

Chapter 3, the Nuclear Medicine Radioisotopes competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Nuclear Medicine Radioisotopes breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Nuclear Medicine Radioisotopes market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Nuclear Medicine Radioisotopes sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview

1.1 Nuclear Medicine Radioisotopes Introduction

1.2 Market Analysis by Type

1.2.1 Thallium-201 (Tl-201)

1.2.2 Iodine (I-123)

1.2.3 Fluorine-18

1.2.4 Rubidium-82 (Rb-82)

1.2.5 Other

1.3 Market Analysis by Applications

1.3.1 Tumor

1.3.2 Heart Disease

1.3.3 Lymphoma

1.3.4 Thyroid Gland

1.3.5 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Agfa-Gevaert Group

2.1.1 Business Overview

2.1.2 Nuclear Medicine Radioisotopes Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Braco

2.2.1 Business Overview

2.2.2 Nuclear Medicine Radioisotopes Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Braco Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Cardiarc

2.3.1 Business Overview

2.3.2 Nuclear Medicine Radioisotopes Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Cardinal Health

2.4.1 Business Overview

2.4.2 Nuclear Medicine Radioisotopes Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 CMR Naviscan (Gamma Medica Inc.)

2.5.1 Business Overview

2.5.2 Nuclear Medicine Radioisotopes Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Curium

2.6.1 Business Overview

2.6.2 Nuclear Medicine Radioisotopes Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Curium Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Digirad

2.7.1 Business Overview

2.7.2 Nuclear Medicine Radioisotopes Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 GE Healthcare

2.8.1 Business Overview

2.8.2 Nuclear Medicine Radioisotopes Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Nordion (Canada)

2.9.1 Business Overview

2.9.2 Nuclear Medicine Radioisotopes Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 NTP Radioisotopes SOC

2.10.1 Business Overview

2.10.2 Nuclear Medicine Radioisotopes Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.11 Positron

2.11.1 Business Overview

2.11.2 Nuclear Medicine Radioisotopes Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Positron Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.12 Segami

2.12.1 Business Overview

2.12.2 Nuclear Medicine Radioisotopes Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Segami Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.13 Siemens Healthcare

2.13.1 Business Overview

2.13.2 Nuclear Medicine Radioisotopes Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Nuclear Medicine Radioisotopes Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Nuclear Medicine Radioisotopes Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Nuclear Medicine Radioisotopes Manufacturer Market Share in 2018

3.3.2 Top 6 Nuclear Medicine Radioisotopes Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Nuclear Medicine Radioisotopes Market Analysis by Regions

4.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Regions

4.1.1 Global Nuclear Medicine Radioisotopes Sales and Market Share by Regions (2014-2019)

4.1.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Regions (2014-2019)

4.2 North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

4.3 Europe Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

4.5 South America Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

5 North America Nuclear Medicine Radioisotopes by Country

5.1 North America Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country

5.1.1 North America Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)

5.1.2 North America Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)

5.2 United States Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

5.3 Canada Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

5.4 Mexico Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

6 Europe Nuclear Medicine Radioisotopes by Country

6.1 Europe Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country

6.1.1 Europe Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)

6.1.2 Europe Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)

6.2 Germany Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

6.3 UK Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

6.4 France Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

6.5 Russia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

6.6 Italy Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

7 Asia-Pacific Nuclear Medicine Radioisotopes by Country

7.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)

7.2 China Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

7.3 Japan Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

7.4 Korea Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

7.5 India Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

8 South America Nuclear Medicine Radioisotopes by Country

8.1 South America Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country

8.1.1 South America Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)

8.1.2 South America Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)

8.2 Brazil Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

8.3 Argentina Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

8.4 Colombia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

9 Middle East and Africa Nuclear Medicine Radioisotopes by Countries

9.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

9.3 Turkey Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

9.4 Egypt Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

9.5 Nigeria Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

9.6 South Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

10 Global Nuclear Medicine Radioisotopes Market Segment by Type

10.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Nuclear Medicine Radioisotopes Sales and Market Share by Type (2014-2019)

10.1.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Type (2014-2019)

10.2 Thallium-201 (Tl-201) Sales Growth and Price

10.2.1 Global Thallium-201 (Tl-201) Sales Growth (2014-2019)

10.2.2 Global Thallium-201 (Tl-201) Price (2014-2019)

10.3 Iodine (I-123) Sales Growth and Price

10.3.1 Global Iodine (I-123) Sales Growth (2014-2019)

10.3.2 Global Iodine (I-123) Price (2014-2019)

10.4 Fluorine-18 Sales Growth and Price

10.4.1 Global Fluorine-18 Sales Growth (2014-2019)

10.4.2 Global Fluorine-18 Price (2014-2019)

10.5 Rubidium-82 (Rb-82) Sales Growth and Price

10.5.1 Global Rubidium-82 (Rb-82) Sales Growth (2014-2019)

10.5.2 Global Rubidium-82 (Rb-82) Price (2014-2019)

10.6 Other Sales Growth and Price

10.6.1 Global Other Sales Growth (2014-2019)

10.6.2 Global Other Price (2014-2019)

11 Global Nuclear Medicine Radioisotopes Market Segment by Application

11.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2014-2019)

11.2 Tumor Sales Growth (2014-2019)

11.3 Heart Disease Sales Growth (2014-2019)

11.4 Lymphoma Sales Growth (2014-2019)

11.5 Thyroid Gland Sales Growth (2014-2019)

11.6 Other Sales Growth (2014-2019)

12 Nuclear Medicine Radioisotopes Market Forecast (2019-2024)

12.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Growth Rate (2019-2024)

12.2 Nuclear Medicine Radioisotopes Market Forecast by Regions (2019-2024)

12.2.1 North America Nuclear Medicine Radioisotopes Market Forecast (2019-2024)

12.2.2 Europe Nuclear Medicine Radioisotopes Market Forecast (2019-2024)

12.2.3 Asia-Pacific Nuclear Medicine Radioisotopes Market Forecast (2019-2024)

12.2.4 South America Nuclear Medicine Radioisotopes Market Forecast (2019-2024)

12.2.5 Middle East and Africa Nuclear Medicine Radioisotopes Market Forecast (2019-2024)

12.3 Nuclear Medicine Radioisotopes Market Forecast by Type (2019-2024)

12.3.1 Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2019-2024)

12.3.2 Global Nuclear Medicine Radioisotopes Market Share Forecast by Type (2019-2024)

12.4 Nuclear Medicine Radioisotopes Market Forecast by Application (2019-2024)

12.4.1 Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2019-2024)

12.4.2 Global Nuclear Medicine Radioisotopes Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Nuclear Medicine Radioisotopes Picture

Table Product Specifications of Nuclear Medicine Radioisotopes

Figure Global Sales Market Share of Nuclear Medicine Radioisoto